Medico Intercontinental Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Medico Intercontinental Ltd. on BSE

Load latest

Medico Intercontinental Ltd.

30 May 2022

40.72

-2.09%

Company Update

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Dear Sir / Ma'am, We hereby wish to inform you that the Audited financial results (Standalone & Consolidated) for the quarter and financial year ended 31st March, 2022 were approved at the meeting of Board of Directors held on Saturday, 28th May, 2022. In continuation to the same, the newspaper clipping duly published in English and Gujarati Newspaper is enclosed herewith. This is for your information and records.

pdf

Medico Intercontinental Ltd.

28 May 2022

40.72

-2.09%

Result

Medico Intercontinental Ltd - 539938 - Declaration Regarding Regulation 23 (9) Of SEBI (Listing Obligations And …

BSE India

As per the provisions of 15(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('LODR Regulations'), the compliances with corporate governance provisions as specified in Regulations 17 to 27 are applicable to the Company only if it's paid up Capital exceeds Rs. 10 Crores and if Net worth is above Rs. 25 Crores. As on 31st March, 2022, the paid up share capital of the company is Rs. 3,24,90,000/- (Rupees Three Crores Twenty Four Lakhs Ninety Thousand only) which does not exceed Rs. 10 Crores limit and the Net Worth of the Company is Rs. 7,65,20,109/- (Rupees Seven Crores Sixty Five Lakhs Twenty thousand One Hundred and Nine only) which does not cross Rs. 25 Crores. Hence, the compliance of provisions of Regulations 17 to 27 of SEBI (LODR) Regulations, 2015 is not applicable to the Company. In light of the above, the Company do not fall under the ambit of Regulation 23 (9) of SEBI (LODR) Regulations, 2015. Kindly take the same on record.

pdf

Medico Intercontinental Ltd.

28 May 2022

40.72

-2.09%

Result

Medico Intercontinental Ltd - 539938 - Results - Financial Year Ended 31St March 2022

BSE India

Dear Sir/Ma'am, Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., May 28, 2022 as per attached PDF. The Board Meeting of the Company commenced at 11:45 AM and concluded at 03:20 PM. This is for your information and records.

pdf

Medico Intercontinental Ltd.

28 May 2022

40.72

-2.09%

Result

Medico Intercontinental Ltd - 539938 - Board Meeting Outcome for Outcome Of Board Meeting And Compliances …

BSE India

Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., May 28, 2022 as per the PDF attached. The Board Meeting of the Company commenced at 11:45 AM and concluded at 03:20 PM. This is for your information and records.

pdf

Medico Intercontinental Ltd.

28 May 2022

40.72

-2.09%

Company Update

Medico Intercontinental Ltd - 539938 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Non - Applicability of provisions of Reg. 24A of SEBI (LODR), Regulations- relating to Annual Secretarial Compliance Report for the year ended 31st March, 2022.

pdf

Medico Intercontinental Ltd.

28 May 2022

40.72

-2.09%

Annual Report

Annual report for Medico Intercontinental Ltd. for FY-2022

None

pdf

Medico Intercontinental Ltd.

21 May 2022

40.72

-2.09%

Board Meeting

Medico Intercontinental Ltd - 539938 - Board Meeting Intimation for Intimation Of Board Meeting In Compliance …

BSE India

Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2022 ,inter alia, to consider and approve With reference to the captioned subject, we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Saturday, 28th May, 2022 at the registered office of the Company situated at 1-5th Floor, Aditraj Arcade, Nr Karma Shreshtha Tower, 100 Ft Rd, Satellite, Ahmedabad, Gujarat - 380015, to inter alia consider, approve and take on record the Audited Financial Results (Standalone and Consolidated) for quarter and financial year ended 31st March, 2022 and any other business items as per agenda circulated. You are requested to kindly take the same on your record.

pdf

Medico Intercontinental Ltd.

12 May 2022

40.72

-2.09%

Company Update

Medico Intercontinental Ltd - 539938 - Reply To The Clarification Sought By Stock Exchange

BSE India

With reference to your email dated 11/05/2022, we wish to inform you that the Company has made all the necessary disclosures pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and has not withheld any material information/event that in our opinion would have bearing on the price/volume behavior of the scrip. The Company shall continue to make applicable disclosures, within the stipulated time. Therefore, the increase in the share price / volume of the company is purely due to market conditions and absolutely market driven and the management of the company is in no way connected with any such increase in price / volume. You are requested to take the same on record.

pdf

Medico Intercontinental Ltd.

12 May 2022

40.72

-2.09%

Company Update

Medico Intercontinental Ltd - 539938 - Clarification sought from Medico Intercontinental Ltd

BSE India

The Exchange has sought clarification from Medico Intercontinental Ltd on May 11, 2022 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.

Medico Intercontinental Ltd.

07 Apr 2022

40.72

-2.09%

Company Update

Medico Intercontinental Ltd - 539938 - Format of Initial Disclosure to be made by an entity …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayMedico Intercontinental Ltd 2CINL24100GJ1984PLC111413 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 7.00 4Highest Credit Rating during the previous FY 0 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: PUNEETA SHARMA Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER EmailId: mail@medicointercontinental.com Name of the Chief Financial Officer: JAY SHARADKUMAR SHAH Designation: CHIEF FINANCIAL OFFICER EmailId: mail@medicointercontinental.com Date: 07/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Is Medico Intercontinental Ltd. worth buying?

33 Votes:

Buy 75.76%

Sell 12.12%

Hold 12.12%